MTOR and neoplasm: As research on angiogenesis in tumor development progressed, treatment strategies targeting the vascular endothelial growth factor (VEGF) pathway emerged, along with a series of other approaches such as targeting the mammalian target of mTOR pathway (rapamycin) and immune checkpoint blockers [39].